Abstract | BACKGROUND: METHODS: RESULTS: Among the 439 included patients, the mean age was 42.2 years, and 69.7% were female. The average duration of lurasidone treatment across all patients was 55.2 days and follow-up duration after the index date was 225.1 days. The estimated impact of lurasidone on weight was - 0.77 kg at the end of the 1-year follow-up. Patients who had received a prior second-generation antipsychotic with medium/high risk for weight gain were estimated to lose an average of 1.68 kg at the end of the 1-year follow-up. CONCLUSIONS:
|
Authors | Jonathan M Meyer, Daisy S Ng-Mak, Chien-Chia Chuang, Krithika Rajagopalan, Antony Loebel |
Journal | Annals of general psychiatry
(Ann Gen Psychiatry)
Vol. 16
Pg. 36
( 2017)
ISSN: 1744-859X [Print] England |
PMID | 29075309
(Publication Type: Journal Article)
|